Antibiotic resistance is when a bacterium or fungus becomes resistant to antibiotics. This resistance can be developed when microbes are exposed to antibiotics. This antibiotic resistance can be transmitted and spread between pathogenic bacteria, bacteria on our body and bacteria in the environment. Overuse and often incorrect use are the main reasons for the spread of the phenomenon. This phenomenon is often called « The invisible epidemic »
In France, there are over 150,000 infections per year with multi-drug resistant bacteria, resulting in the death of 12,500 patients. This figure increases to more than 33,000 patients in Europe.
Covid-19 has even accelerated and worsened the phenomenon; according to the Center for Disease Control and Prevention, in the first year of the pandemic more than 29,400 people died as a result of infections associated with multi-antibiotic resistant bacteria.
In the first year of the pandemic, more than 80% of patients hospitalised for covid received an antibiotic. Antibiotic resistance is one of the most serious threats to global health, as well as being a socio-economic problem.
The financial cost of care
OMS, Santé Publique France and European Centre for Disease Control and Prevention (ECDC)